Go Deep
Bodal Chemicals Limited
Bodal Chemicals Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 22,416 | 35.2 | 2.09 | 0.70 | 191.99 |
| Oct 2026 | 22,248 | 34.8 | 2.06 | 0.70 | 189.75 |
| Oct 2026 | 22,101 | 31.7 | 1.88 | 0.70 | 172.59 |
Bodal Chemicals Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 7,090,410,000.0 | 5,880,180,000.0 | 4,895,690,000.0 | 4,804,520,000.0 |
| Net Profit | 303,790,000.0 | 320,600,000.0 | 2,420,000.0 | 59,930,000.0 |
| EPS | 2.4 | 2.5 | 0.0 | 0.5 |
Bodal Chemicals Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 19,500,270,000.0 | 17,096,040,000.0 | 13,629,420,000.0 | 15,444,740,000.0 |
| Net Profit | 478,280,000.0 | 185,020,000.0 | 64,690,000.0 | 380,330,000.0 |
| EPS | 3.8 | 1.5 | 0.5 | 3.0 |
Bodal Chemicals Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 23,557,740,000.0 | 23,529,040,000.0 | 22,878,800,000.0 | 21,209,000,000.0 | — |
| Total Liabilities | 11,982,300,000.0 | 12,480,570,000.0 | 12,056,390,000.0 | 10,431,970,000.0 | — |
| Total Equity | 11,575,440,000.0 | 11,048,470,000.0 | 10,822,410,000.0 | 10,777,030,000.0 | — |
Owes vs Owns
Bodal Chemicals Limited owed ₹0.51 for every ₹1 it owned in Mar 2026, up from ₹0.49 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.51× | 0.53× | 0.53× | 0.49× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Bodal Chemicals Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 0.7%Receivables 18.6%Inventory 13.7%Fixed assets (tangible) 55.5%Other assets 10.9%
How it's funded — Mar 2026
Short-term debt 19.5%Long-term debt 14.4%Payables 10.5%Other liabilities 6.4%Shareholders' equity 49.1%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 16.8 | 23.5 | 36.9 | 16.8 |
| Receivables | 438.6 | 398.9 | 380.8 | 420.3 |
| Inventory | 323.6 | 337.2 | 267.2 | 292.5 |
| Fixed assets (tangible) | 1,307.8 | 1,364.3 | 1,394.1 | 1,210.1 |
| Intangible assets | 11.5 | 12.5 | 13.5 | 14.5 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.2 |
| Other assets | 257.4 | 216.5 | 195.3 | 166.4 |
| Liabilities & equity | ||||
| Short-term debt | 460.0 | 499.5 | 454.8 | 335.6 |
| Long-term debt | 340.2 | 406.5 | 443.0 | 361.8 |
| Payables | 246.8 | 236.3 | 195.3 | 239.7 |
| Other liabilities | 151.2 | 105.8 | 112.5 | 106.0 |
| Shareholders' equity | 1,157.5 | 1,104.8 | 1,082.2 | 1,077.7 |
| Net tangible assets | 1,146.0 | 1,092.4 | 1,068.8 | 1,063.2 |
Bodal Chemicals Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 1,759,730,000.0 | 1,137,820,000.0 | 2,042,460,000.0 | 2,898,960,000.0 | — |
| Investing Activities | 106,540,000.0 | -370,100,000.0 | -2,616,350,000.0 | -3,100,630,000.0 | — |
| Financing Activities | -1,914,580,000.0 | -734,560,000.0 | 809,810,000.0 | 326,550,000.0 | — |